Regenxbio Inc (RGNX)

Debt-to-capital ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Long-term debt US$ in thousands
Total stockholders’ equity US$ in thousands 311,742 363,100 405,855 465,139 516,195 563,824 630,519 689,669 764,298 461,414 507,245 554,504 377,753 415,660 397,861 420,152 450,197 468,395 494,592 487,053
Debt-to-capital ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

December 31, 2023 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $311,742K)
= 0.00

The debt-to-capital ratio of Regenxbio Inc has remained consistently at 0.00 across all quarters of the past two years. This indicates that the company has not utilized any debt to finance its operations or growth initiatives during this period. A debt-to-capital ratio of 0.00 typically suggests that the company relies solely on equity financing, which can be advantageous as it reduces the financial risk associated with debt obligations. However, it's also worth noting that excessive reliance on equity financing may limit the company's ability to take advantage of leverage and potentially higher returns on investment.


Peer comparison

Dec 31, 2023